South African Tuberculosis Vaccine Initiative

Published trials3

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

3 shown

Study to Evaluate H56:IC31 in Preventing Rate of TB RecurrenceNCT03512249 · collaborator · 2019-01-31

Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment CompletionNCT02465216 · collaborator · 2015-06-01

COMPLETED

Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South AfricaNCT02391415 · collaborator · 2015-06-01

COMPLETED

Sponsor roles

collaborator3

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.